Elypta
Elypta is developing the first liquid biopsy platform based on cancer metabolism.
Elypta has raised €27M across 3 funding rounds from 9 investors, most recently a round in Apr 2023. Based in Stockholm, Sweden; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€27M
€26,856,362
Funding rounds
3
Investors
9
distinct backers
Active since
2020-01
latest 2023-04
Funding by year
EUR raised per yearElypta — funding by year — interactive chart.
Data table
| Elypta — funding by year | |
|---|---|
| 2020 | €6.0M |
| 2022 | €20M |
| 2023 | €889k |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-04 | Other | €889k | The Roddenberry Foundation | View deal → |
| 2022-06-20 | Series A | €20M | Bonnier Ventures,Chalmers Ventures,Hillclimber,Industrifonden,Navigare Ventures,Nina Capital+1 more | View deal → |
| 2020-01-23 | Seed | €6.0M | Industrifonden,Sciety | View deal → |
Investors
9Related news
- Vill bota cancer och backas av Norrsken – nu får Elypta 10 miljoner av Star Trek-skaparenbreakit.se · 2023-04
- Swedish biotech company grabs $21M Series A to detect early stage cancerarcticstartup.com · 2022-06
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData